Spots Global Cancer Trial Database for biochemical recurrence
Every month we try and update this database with for biochemical recurrence cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624 | NCT05781217 | Prostate Cancer Salvage Radioth... Biochemical Rec... Androgen Depriv... Metastases-free... | triptorelin, go... | 18 Years - | Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic | |
| Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence | NCT02070575 | Prostate Cancer | blood draw | 30 Years - | Memorial Sloan Kettering Cancer Center | |
| Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer | NCT05753566 | Prostate Cancer Biochemical Rec... | Rezvilutamide Androgen depriv... SRT | 40 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| PROvenge Treatment and Early Cancer Treatment | NCT00779402 | Prostate Cancer | Control Sipuleucel-T | 18 Years - 80 Years | Dendreon | |
| Adjutant Apalutamide Plus ADT in Post-RP Patients With High Risk of Recurrence (ARES Study) | NCT05778097 | Prostate Cancer Biochemical Rec... High Risk | Apalutamide 60m... Androgen depriv... | 18 Years - 75 Years | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| LIpitor and biGuanide to Androgen Delay Trial | NCT02497638 | Prostate Cancer | Metformin Atorvastatin Placebo (corres... Placebo (corres... | 18 Years - 80 Years | University Health Network, Toronto | |
| PSMA-PET/CT for Prostate Cancer | NCT03558711 | Prostate Cancer | 18F-PSMA | 40 Years - 70 Years | University Hospital, Ghent | |
| Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7 | NCT05622162 | Prostate Cancer 18F- Fluorochol... PSMA PET Radiotherapy Prostatectomy Tumor of Prosta... | Radiopharmaceut... Radiopharmaceut... | 18 Years - | ITEL Telecomunicazioni Srl | |
| LIpitor and biGuanide to Androgen Delay Trial | NCT02497638 | Prostate Cancer | Metformin Atorvastatin Placebo (corres... Placebo (corres... | 18 Years - 80 Years | University Health Network, Toronto | |
| Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformin | NCT04536805 | Prostate Cancer | Metformin Stereotactic Bo... Stereotactic Bo... Stereotactic Bo... | 18 Years - | Institut Cancerologie de l'Ouest | |
| Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer | NCT06305832 | Prostate Cancer Biochemical Rec... | Rezvilutamide Androgen depriv... SRT | 40 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformin | NCT04536805 | Prostate Cancer | Metformin Stereotactic Bo... Stereotactic Bo... Stereotactic Bo... | 18 Years - | Institut Cancerologie de l'Ouest | |
| PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma | NCT01304485 | Prostate Cancer | Sodium Acetate ... | 18 Years - | Phoenix Molecular Imaging | |
| PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma | NCT01304485 | Prostate Cancer | Sodium Acetate ... | 18 Years - | Phoenix Molecular Imaging | |
| Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence | NCT02070575 | Prostate Cancer | blood draw | 30 Years - | Memorial Sloan Kettering Cancer Center | |
| PSMA PET/CT for Prostate Cancer | NCT03573011 | Prostate Cancer | [18F]PSMA-11 | 18 Years - | University Hospital, Ghent | |
| Apalutamide Plus Intermittent Hormone Therapy Versus Intermittent Hormone Therapy Alone in Prostate Cancer | NCT02811809 | Prostate Cancer | Apalutamide IHT | 18 Years - | The University of Texas Health Science Center, Houston | |
| PSMA-RLT in Biochemically Recurrent PCa | NCT06220188 | Prostate Cancer... | [177Lu]Lu-PSMA ... | 18 Years - 80 Years | Medical University of Vienna | |
| Adjutant Apalutamide Plus ADT in Post-RP Patients With High Risk of Recurrence (ARES Study) | NCT05778097 | Prostate Cancer Biochemical Rec... High Risk | Apalutamide 60m... Androgen depriv... | 18 Years - 75 Years | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7 | NCT05622162 | Prostate Cancer 18F- Fluorochol... PSMA PET Radiotherapy Prostatectomy Tumor of Prosta... | Radiopharmaceut... Radiopharmaceut... | 18 Years - | ITEL Telecomunicazioni Srl |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
